These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 32533218)

  • 1. Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular system.
    Michel L; Totzeck M; Lehmann L; Finke D
    Herz; 2020 Nov; 45(7):645-651. PubMed ID: 32533218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity from immune checkpoint inhibitors.
    Michel L; Rassaf T; Totzeck M
    Int J Cardiol Heart Vasc; 2019 Dec; 25():100420. PubMed ID: 31517036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Checkpoint Inhibitor (ICI)-Related Cardiotoxicity.
    Zarifa A; Lopez-Mattei J; Palaskas NL; Iliescu C; Durand JB; Kim PY
    Adv Exp Med Biol; 2021; 1342():377-387. PubMed ID: 34972975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
    Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
    Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity of Immune Checkpoint Inhibitors.
    Patel RP; Parikh R; Gunturu KS; Tariq RZ; Dani SS; Ganatra S; Nohria A
    Curr Oncol Rep; 2021 May; 23(7):79. PubMed ID: 33937956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors.
    Dolladille C; Ederhy S; Allouche S; Dupas Q; Gervais R; Madelaine J; Sassier M; Plane AF; Comoz F; Cohen AA; Thuny FR; Cautela J; Alexandre J
    J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31988143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
    Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
    Mahmood SS; Fradley MG; Cohen JV; Nohria A; Reynolds KL; Heinzerling LM; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Awadalla M; Hassan MZO; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Lawrence DP; Groarke JD; Neilan TG
    J Am Coll Cardiol; 2018 Apr; 71(16):1755-1764. PubMed ID: 29567210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiotoxicity of immune checkpoint inhibitors used in cancer treatment].
    Arangalage D; Pavon AG; Hugelshofer S; Desgraz B; Tzimas G; Delyon J; Muller O; Obeid M; Ribi C; Michielin O; Özdemir BC; Monney P
    Rev Med Suisse; 2020 Jun; 16(696):1165-1168. PubMed ID: 32496706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and solutions in management of cardiotoxicity induced by checkpoint inhibitors.
    Mladosievičová B; Országhová Z; Jablonická M; Rečková M; Chovanec M; Mego M
    Klin Onkol; 2020; 33(5):350-355. PubMed ID: 33108879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular toxicity of immune checkpoint inhibitors in cancer patients: A review when cardiology meets immuno-oncology.
    Chen DY; Huang WK; Chien-Chia Wu V; Chang WC; Chen JS; Chuang CK; Chu PH
    J Formos Med Assoc; 2020 Oct; 119(10):1461-1475. PubMed ID: 31444018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Checkpoint Inhibitor Cardiotoxicity: Understanding Basic Mechanisms and Clinical Characteristics and Finding a Cure.
    Waliany S; Lee D; Witteles RM; Neal JW; Nguyen P; Davis MM; Salem JE; Wu SM; Moslehi JJ; Zhu H
    Annu Rev Pharmacol Toxicol; 2021 Jan; 61():113-134. PubMed ID: 32776859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine assessment of cardiotoxicity in patients undergoing long-term immune checkpoint inhibitor therapy.
    Tamura Y; Tamura Y; Yamada K; Taniguchi H; Iwasawa J; Yada H; Kawamura A
    Heart Vessels; 2022 Nov; 37(11):1859-1865. PubMed ID: 35633369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity.
    Khunger A; Battel L; Wadhawan A; More A; Kapoor A; Agrawal N
    Curr Oncol Rep; 2020 Jun; 22(7):65. PubMed ID: 32514647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors.
    Awadalla M; Golden DLA; Mahmood SS; Alvi RM; Mercaldo ND; Hassan MZO; Banerji D; Rokicki A; Mulligan C; Murphy SPT; Jones-O'Connor M; Cohen JV; Heinzerling LM; Armanious M; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Rizvi MA; Sahni G; Lyon AR; Tocchetti CG; Mercurio V; Thuny F; Ederhy S; Mahmoudi M; Lawrence DP; Groarke JD; Nohria A; Fradley MG; Reynolds KL; Neilan TG
    J Immunother Cancer; 2019 Feb; 7(1):53. PubMed ID: 30795818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-organ Immune-Related Adverse Event Is a Risk Factor of Immune Checkpoint Inhibitor-Associated Myocarditis in Cancer Patients: A Multi-center Study.
    Xie X; Wang L; Li Y; Xu Y; Wu J; Lin X; Lin W; Mai Q; Chen Z; Zhang J; Xie Z; Qin Y; Liu M; Lu M; Luo B; Zhou C
    Front Immunol; 2022; 13():879900. PubMed ID: 35924238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Inhibitor-Related Myocarditis: Recognition, Surveillance, and Management.
    Kuhnly NM; Coviello J
    Clin J Oncol Nurs; 2022 Feb; 26(1):54-60. PubMed ID: 35073300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Immune Checkpoint Inhibitor-Mediated Cardiovascular Toxicities.
    Yousif LI; Screever EM; Versluis D; Aboumsallem JP; Nierkens S; Manintveld OC; de Boer RA; Meijers WC
    Curr Oncol Rep; 2023 Jul; 25(7):753-763. PubMed ID: 37079251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular toxicities associated with immune checkpoint inhibitors.
    Hu JR; Florido R; Lipson EJ; Naidoo J; Ardehali R; Tocchetti CG; Lyon AR; Padera RF; Johnson DB; Moslehi J
    Cardiovasc Res; 2019 Apr; 115(5):854-868. PubMed ID: 30715219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.
    Vasbinder A; Ismail A; Salem JE; Hayek SS
    Curr Cardiol Rep; 2023 Sep; 25(9):959-967. PubMed ID: 37436648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.